0001209191-19-039702.txt : 20190701
0001209191-19-039702.hdr.sgml : 20190701
20190701161447
ACCESSION NUMBER: 0001209191-19-039702
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190627
FILED AS OF DATE: 20190701
DATE AS OF CHANGE: 20190701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Jeffery W.
CENTRAL INDEX KEY: 0001663552
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 19933361
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER NAME:
FORMER CONFORMED NAME: Kelly Jeffrey W.
DATE OF NAME CHANGE: 20160113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-225-0096
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
STREET 2: 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-27
0
0001445283
PROTEOSTASIS THERAPEUTICS, INC.
PTI
0001663552
Kelly Jeffery W.
C/O PROTEOSTASIS THERAPEUTICS, INC.
80 GUEST STREET, 5TH FLOOR
BOSTON
MA
02135
1
0
0
0
Stock Option (Right to Buy)
0.94
2019-06-27
4
A
0
15300
0.00
A
2029-06-27
Common Stock
15300
15300
D
These securities shall vest and become exercisable in equal quarterly installments starting on June 27, 2019 until the option is fully vested and exercisable on June 27, 2020, subject to continued service.
/s/ Janet L. Smart, Attorney-in-Fact
2019-07-01